The 8th Annual Optimizing Clinical trials Summit: Site Selection, Feasibility & Patient Recruitment

Date: 11-Nov-14 to 13-Nov-14
Location: TBA / Barcelona / Spain
Category: Conferences & Trade Fairs

In continuation to our highly successful Optimizing Clinical Trials series, this event will examine site selection, feasibility and patient recruitment strategies; key regulatory changes and the effects they have on market access, best practice techniques in clinical operations and also we will address the need to ensure safety and transparency. Attend the 8th Annual Optimizing Clinical Trials Summit: Site Selection, Feasibility & Patient Recruitment and learn more about best practices, regulatory developments, industry trends, tips and tools of pharma experts from Bayer, Pfizer, Roche, AstraZeneca, and Teva just to name a few, all of which will allow you to increase your own success in clinical research.

Visitors

The 8th Annual Optimizing Clinical Trials Summit: Site Selection, Feasibility & Patient Recruitment is designed for Members of the Board, Vice Presidents, Directors, Head and Senior Managers from pharmaceutical industry involved in:

Clinical Program Management
Clinical Operations
Europe Clinical Operations
EU Study Start Up Unit
Global Clinical Research
Clinical Trials
Global Clinical Development
Clinical Program Director
Medical Director
Global Project Management
Clinical Research
Development Operations

Exhibitors

Is your company offering solutions or consulting services for clinical trials in the pharmaceutical industry?

If you provide solutions for clinical trials in the pharma industry then the ability to meet senior decision makers from the industry represents a unique opportunity and extensive exposure to your brand. We value quality over quantity, and as such our clients that you will be networking with are strictly senior decision makers within their respective companies.

Go to event website

EIN News provides powerful, real-time media monitoring, news aggregation & syndication services. Read the latest news about this topic. See: